Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06709716 · ClinicalTrials.gov registry record · Phase 4
Impact of Preoperative Quadratus Lumborum Block on Postoperative Opioid Consumption After Laparoscopic Hysterectomy
A Phase 4 study, sponsored by Walter Reed National Military Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
NCT06709716 is a Phase 4 study that has not yet begun recruiting, run by Walter Reed National Military Medical Center. The registered enrollment target is 76 participants.
The verdict
NCT06709716, a Phase 4 study, has not yet begun recruiting, sponsored by Walter Reed National Military Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if preoperative nerve block (quadratus lumborum \[QL\] block) works to improve pain control during and after laparoscopic hysterectomy. The main questions it aims to answer are: Does QL block decrease the amount of narcotic medication needed during surgery? Does QL block decrease the amount of narcotic medication needed after surgery? Researchers will compare QL block to local injection of a numbing medication at each incision site (the current standard practice) to see if QL block works to decrease surgical pain. Participants will be randomly assigned to receive one of the two following interventions: 1. QL block before surgery with a long-acting numbing medicine (liposomal bupivacaine) and then injection of placebo (saline) at each incision site in the operating room. 2. QL block before surgery with placebo (saline) and then injection of local numbing medicine (bupivacaine) at each incision site in the operating room. Participants will also: * Visit the clinic/hospital for a pre-operative appointment, the surgical procedure, and a 4-6 week post-operative appointment (all standard visits even if not participating in research) * Complete a questionnaire electronically, or by phone, that takes \<10 minutes at the pre-operative appointment and on postoperative days 1, 3, 5, 14, and 4-6 weeks.
Interventions
- DRUG Quadratus Lumborum Block (QLB)
- DRUG Local Anesthetic Solution
- DRUG Quadratus lumborum block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2026-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06709716
The ClinicalTrials.gov registry entry for NCT06709716 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Quadratus Lumborum Block (QLB) is the first listed.
NCT06709716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06709716 about?
NCT06709716 is a clinical study titled "Impact of Preoperative Quadratus Lumborum Block on Postoperative Opioid Consumption After Laparoscopic Hysterectomy". The goal of this clinical trial is to learn if preoperative nerve block (quadratus lumborum \[QL\] block) works to improve pain control during and after laparoscopic hysterectomy. The main questions it aims to answer are: Does QL block decrease the amount of narcotic medication needed during surger...
What is the current status of trial NCT06709716?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2024-12-01. Estimated completion is 2026-02.
What interventions are being tested in trial NCT06709716?
The interventions under investigation include: Quadratus Lumborum Block (QLB) (DRUG), Local Anesthetic Solution (DRUG), Quadratus lumborum block (DRUG).
Who is sponsoring clinical trial NCT06709716?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.